Study design

Primary study design

Secondary study design

Trial setting

Trial type

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Nutritional, Metabolic, Endocrine: Obesity

Intervention

Qualitative and quantitative methods will be used: Questionnaires will be the main quantitative measure. Qualitative data will be collected from 12 participants using semi-structured interviews and narrative approaches, to encapsulate the participants perspective of the strengths and limitations of the study (What helped and what hindered their process?).

Focus Groups will be held monthly with a representative of the Primary Healthcare Team, Counsellors, GPs, patients and therapists involved.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measure

Changes will be assessed at varied time points during the study period. In view of the multiple aims of the project, a range of outcome measures will be utilised. These have been selected for their relevance to this particular client group, sensitivity to change, psychometric properties and clinical (as well as research) utility. The formal outcome measures will be substantiated and supplemented by descriptions of the services offered and the development of the service.

Secondary outcome measures

Not provided at time of registration

Overall trial start date

02/10/2002

Overall trial end date

01/10/2003

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

There are 33 practices within the South East Primary Care Trust (SE PCT). GPs will be asked to recruit a total of 280 participants (8-9 patients per practice) 1. Identified as 'obese patient' (Obesity is most commonly defined by clinicians in terms of body mass index (BMI). A desirable BMI is considered to be in the region of 20 to 25. Anything above this is defined as 'obese') 2. BMI >303. Gender, both males or females accepted4. Age over 16 years, no maximum5. Commitment to the research process for 18 months6. May have mild/moderate chronic illness, diabetes, CHD, irritable bowel syndrome (IBS), back pain7. May have mild/moderate psychological disorders including anxiety and depression